Neoadjuvant Chemotherapy for Newly Diagnosed, Advanced Ovarian Cancer: ASCO Guideline Update
(Abstracted from J Clin Oncol 2025;43(7):868–891 Diagnosis and treatment of ovarian cancer are challenging due to the lack of effective screening tools for advanced stages of disease. Advanced ovarian cancer, classified as the International Federation of Gynecology and Obstetrics stage III or IV, is traditionally treated with primary cytoreductive surgery (PCS) followed by chemotherapy.
Authors
- Larissa A. Meyer (ORCID: https://orcid.org/0000-0002-2687-7463)
- Willemien J. van Driel (ORCID: https://orcid.org/0000-0003-2246-1994)
- Dee Sparacio
- Mitchell I. Edelson (ORCID: https://orcid.org/0000-0001-6708-7380)
- Stéphanie Gaillard (ORCID: https://orcid.org/0000-0002-2174-3693)
- Christina Lacchetti (ORCID: https://orcid.org/0000-0001-6500-713X)
- Jamie Lesnock
- Roisin E. O’Cearbhaill (ORCID: https://orcid.org/0000-0001-8217-4554)
- Alexander Babatunde Olawaiye (ORCID: https://orcid.org/0000-0002-2833-9255)
- William A. Cliby (ORCID: https://orcid.org/0000-0002-7565-9884)
- Kathleen N. Moore (ORCID: https://orcid.org/0000-0002-5803-0718)
- Agustin A. García (ORCID: https://orcid.org/0009-0000-2990-6234)
- William P. Tew (ORCID: https://orcid.org/0000-0001-5115-4470)
- Gregory M. Gressel (ORCID: https://orcid.org/0000-0002-6729-4571)
- Deborah K. Armstrong (ORCID: https://orcid.org/0000-0003-0852-803X)
- Ritu Salani (ORCID: https://orcid.org/0000-0002-5646-343X)
- Rahel G. Ghebre
Publication Details
- Journal
- Obstetrical & Gynecological Survey
- Published
- 2025-07-01
- DOI
- https://doi.org/10.1097/01.ogx.0001125120.19988.fa
- Citations
- 1
- Primary Topic
- Ovarian cancer diagnosis and treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.70